Welcome to the 2026-27 edition of Smash or Pass, in which we examine potential free agent and trade targets to determine whether the Red Sox should pursue them and what it would take to land them. Today, in the wake of an effective veteran pitcher departing for Minnesota, we continue the series with an old friend.
Who is he and where does he come from?
He’s Nick Pivetta. But you know him already. He might as well be from South Boston, but he’s actually from the opposite side of the continent, Vancouver, British Columbia, Canada. After
starting his career in Philadelphia, Dave Dombrowski dealt him to us to get his old reliever Brandon Workman back; the Red Sox would eventually end up with both on the squad, and the deal is widely regarded among Chaim Bloom’s best as Chief Baseball Officer. That’s not because Nick Pivetta was a world-beater, as I’ll get into in just a moment, but he did give the team five very dependable years before heading to San Diego and pitching like a Cy Young Candidate.
Is he any good?
He can be, but there’s a catch. At the age of 33, Pivetta has just sustained his first long-term injury of his entire career. The bad news is, it’s a continuation of an injury he suffered as a member of the Red Sox to start off the 2024 season; this time, the right flexor strain kept him out for five months. So, the jury is out on if he will pitch well in 2027. But, he played meaningful games in October and was one of the best starters in baseball in his last full season in 2025.
The best ability, as we saw from this depleted pitching staff in the late summer, is availability, and Pivetta has had that in spades through his entire career, save for 2026. From 2021-2025, he had an ERA of 4.00 (a 4.04 FIP), a WHIP of 1.18, and 895 strikeouts across 804 2/3 innings. That’s pretty much exactly what you’d be looking for in a back-of-the-rotation starter, though he did have a glaring hole: he allowed home runs and hard hits an alarming rate, and he allowed among the worst rates in baseball (~10th percentile) in barrel percentage for his entire time in Boston. This reared its head in a major way in 2023, when Pivetta was demoted to the bullpen, where he looked like a different guy before winning a rotation spot back, all prior to heading for the west coast in free agency on a 4-year, 55 million dollar deal with opt outs after two years after initially turning down a qualifying offer from the Red Sox. And, after that second season, here we are!
Tl;dr, just give me the 2026 stats.
Remember, that flexor strain kept his season dramatically short, so here’s his last two campaigns.
2025: 13-5, 181 2/3 IP, 190 K, 50 BB, 2.87 ERA, 3.49 FIP
2026: 3-2, 34 2/3 IP, 42 K, 8 BB, 2.86 ERA, 2.21 FIP
Why would he be a good fit for the Sox?
With Sonny Gray going to the Twins, they’re in the market for a right-handed pitcher. Pivetta is four years younger than Gray. He also has been healthy for a good amount of his career; he even made 33 starts in 2023. He knows the team, and was even on the team for the first part of Craig Breslow’s time with the organization. Need I remind everyone how awesome this post-season relief appearance was where he struck seven Rays out in four innings in extras?
We all know how John Henry operates, so maybe the most important thing: he’s also likely to be cost-effective. That plays a huge part for a pitching staff that needs not only depth and dependability, but financial pliability. Payton Tolle is going to need money soon. Garrett Crochet already got paid. Jake Bennett could be a part of this rotation for a while and has a definitively higher ceiling than Pivetta’s, though that’s comparing apples to bananas. Ranger Suarez looked awesome for much of last season. Then there’s Brayan Bello. Fact of the matter is, Pivetta gives a short-term lilypad for this frog of a roster to jump to the next lilypad without having to pay a guy 27 million dollars a season.
Why wouldn’t he be a good fit for the Sox?
First of all, maybe the rotation is already too cluttered, though that argument may have flown the coop once Jedixson Paeztook the mound on a September evening in the middle of a playoff push. You can almost not have too much depth. There are two more important concerns: one is obviously that right flexor. It was an issue two seasons ago, and it kept him out for most of this past season. Now, he posted a 1.45 ERA in five starts once returning from this injury to end 2026 and was healthy enough to take two starts in the postseason, but none of those reached the end of the fifth inning, so it’s equal parts likely it’s going to be an reoccurring issue that just happens as a pitcher ages, or a reason to not invest in him at all. At 34, it may be better to be cautiously pessimistic, knowing you have an effective rotation already.
What would it take to get him?
The Padres declined a $14 million club option, so the Padres don’t want him at that number, but most estimates (including my own, based off of seeing that Gray deal) place him at around $16-17 million AAV and most have him getting a 3-year deal. I’d imagine that this would include opt outs after each year given the recent injury and Pivetta approaching 35 before Opening Day 2028 (Valentine’s Day, to be exact.) Recall that Sonny Gray, who was lights out for the whole season, cost the Red Sox $21 million net after the Cardinals sent money the team’s way to acquire him, and also factor into the equation that a Tolle deal is on the horizon… somewhere. There are other options, like Michael King, Nick Martinez, and Casey Mize, but if Dustin May’s 3 year, 52.5 million deal is any indication of what these guys will cost, Pivetta will be more cost-efficient.
Smash or Pass?
I’m smashing if the thought process is securing Tolle to a long term deal, and that Garrett Crochet reemerges as the pig he was in 2025, and Ranger Suarez is sorted onto this 2027 squad as arguably the best third man in all of baseball. Nick Pivetta could easily be a fifth man in this rotation, and, as we know, the allotment this year may be even tighter than most, especially given a couple of dominos have already fallen: I’d rather use his limited allotment to bolster a lineup to gather some run support for a rotation that was not the biggest issue for a playoff squad and stick to a lower-risk addition we already know well.













